Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Chinese researchers synthesize new SOS1 inhibitors

Jan. 4, 2022

Medshine Discovery discloses EZH2 inhibitors

Jan. 4, 2022

YAP1 promotes salivary gland regeneration after injury

Jan. 4, 2022

Siglec-15 promotes osteosarcoma tumor progression

Jan. 3, 2022

Novel halogenated phenoxychalcones described with activity in breast cancer cell lines

Jan. 3, 2022

Mission Therapeutics synthesizes USP30 inhibitors

Jan. 3, 2022

Betta Pharmaceuticals divulges new PTPN11 inhibitors

Jan. 3, 2022

Chinese researchers disclose SOS1 inhibitors

Jan. 3, 2022

Discovery of novel BU-4664L derivatives with potential anticancer activity

Jan. 3, 2022

GMQ-3 shows promising efficacy in models of lung cancer

Jan. 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...